A - AGILENT TECHNOLOGIES, INC.
Close
139
0 0%
Share volume: 0
Last Updated: Fri 20 Dec 2024 09:00:37 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.51%
PREVIOUS CLOSE
CHG
CHG%
$139.00
-5.63
0.04%
Fundamental analysis
58%
Profitability
54%
Dept financing
39%
Liquidity
75%
Performance
62%
Performance
5 Days
-3.25%
1 Month
3.59%
3 Months
-4.93%
6 Months
0.35%
1 Year
-3.61%
2 Year
-9.96%
Key data
Stock price
$139.00
DAY RANGE
$133.37 - $139.00
52 WEEK RANGE
$126.24 - $155.35
52 WEEK CHANGE
-$4.57
DIVIDEND
$0.236
EX-DIVIDEND DATE
07/02/2024
NEXT EARNINGS DATE
11/18/2024
Company detail
CEO: Michael R. McMullen
Region: US
Website: agilent.com
Employees: 18,100
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: agilent.com
Employees: 18,100
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, and genetic data management.
Recent news